As HHS Secretary, Kennedy cut nearly $500 million in funding for mRNA vaccine research. While he says that the decision was made after looking at the science, health experts have heavily criticized ...

The clinical hold is due to questions about BX004’s nebulizer device, temporarily pausing US enrollment in the cystic ...

The regulatory body determined that PTC Therapeutics’ New Drug Application for vatiquinone did not provide sufficient ...

Pharm Exec unveils its new slate of rising leaders in the biopharma industry—profiling the stories of five executives ...

Rob Abbott, CEO, ISPOR, highlights how uniting regulators, payers, and academic leaders worldwide can accelerate access to innovative treatments and strengthen evidence-based healthcare.

EMD Serono recently named Miguel Fernandez Alcalde as its new president. The new executive spoke with Pharmaceutical ...

The move is likely part of the company’s goal to reduce costs as it faces increased competition in the GLP-1 space.

The MFN executive order introduces uncertainty in pharma pricing strategies, necessitating careful risk assessment and ...

The disease doesn’t have any FDA approved treatments, leaving families desperate for FDA to approve the treatment.

Ron Lanton, partner, Lanton Law, warns that ongoing lawsuits targeting vaccine policy could create ripple effects across FDA ...

The collaboration will explore RNA-based small molecule drug candidates aimed at neurological conditions where existing ...

Novo Nordisk reduces Ozempic's price to $499/month for self-paying patients, enhancing access to essential diabetes treatment ...